![Devyser Diagnostics, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/9bb34f53-cefc-4dd5-9146-2b3edff3a4ef.png)
Devyser Diagnostics
111.5 SEK +1.36%1 investor is following this company
Devyser Diagnostics develops, manufactures, and sells genetic tests to laboratories globally. The products are used for DNA tests in oncology, transplantation, and hereditary diseases to enable tailored cancer treatment, diagnosis of a large number of genetic diseases, and follow-up of transplant patients. The company is headquartered in Hägersten.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
DVYSR
Daily low / high price
108.5 / 112
SEK
Market cap
1.84B SEK
Turnover
420.99K SEK
Volume
3.8K
Latest videos
Financial calendar
Interim report
2024-10-30
Annual report
2025-02-13
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Rutger Arnhult, via bolag | 24.2 % | 24.2 % |
Nordnet Pensionsförsäkringar | 8.3 % | 8.3 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
![Devyser Diagnostics, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/9bb34f53-cefc-4dd5-9146-2b3edff3a4ef.png)
Devyser Diagnostics AB publicerar kvartalsrapport för april till juni 2024
Devyser Diagnostics AB publishes quarterly report for the period April to June 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools